WRN and cancer: Interestingly, CPT treatment leads to the degradation of WRN (Shamanna et al., 2016a; Li et al., 2020), suggesting that cancers with microsatellite instability may be a candidate target for CPT treatment to drive WRN-specific vulnerable tumors.